Patent Portfolio Covering Bone and Tissue Regeneration Technology Developed by the German Company, Magnetodyn, to be Sold by Munich Innovation Group

Munich, Germany (July 3, 2014) – Munich Innovation announces the opportunity to acquire the patented know-how of Magnetodyn, the leading company in the technology of bone and tissue regeneration using activatable implants for electromagnetic deep tissue stimulation.

The technology is protected by a strong patent portfolio that spans 10 independent patent families, including 31 granted patents and 29 active patent applications in the US, EU and Worldwide.

Stimulation of the biology of fracture healing is one of the lead topics in fracture treatment today. Magnetodyn technology has demonstrated its effectiveness with over 8,000 implants to date, in a wide range of applications, making it the clinically most proven and effective bone and tissue regeneration therapy in the field.

The Magnetodyn technology is applied in orthopedics, trauma and wound care and is particulary effective in infection control. In its invasive form, a standard orthopedic implant is transformed into an active device for the stimulation of the healing process without requiring any change in established surgical procedures. In its non-invasive form, Magnetodyn offers a stimulation pathway for accelerated wound healing.

„We believe that the combined use of sinusoidal electric and magnetic fields using orthopedic and trauma implants for the treatment of bone and soft tissue defects patented by Magnetodyn is unique in terms of scope of treatment, indication range, treatment duration, and success rate“, says Stephanie Kraus, CEO of Magnetodyn.

„The Magnetodyn patent portfolio and know-how represents a unique opportunity for a company either already active in the field of bone and tissue stimulation, or otherwise well-entrenched in the medical industry, to enhance an existing, or create a new, business line with a strong USP“, says Dr. Stefan Taing, Senior Partner of Munich Innovation.

The Magnetodyn patented technology and the associated product portfolio cover the key markets of orthopedics, trauma and wound healing, all of which are expanding rapidly. Magnetodyn offers a competitive advantage in the orthopedics market (valued at $6bn in 2014 and anticipated to grow to $7.5bn by 2020) through its superior implant lifetime and revision management.

Munich Innovation will shortly be approaching potential buyers of the patent portfolio with a comprehensive information memorandum and will be available to discuss the intellectual property in further detail.

To receive more information about this opportunity, please contact Wolfgang Maennel at wm@munich-innovation.com.

Munich Innovation Group GmbH is a leading service provider for intellectual property monetization and research on a global scale. Clients include publicly listed high-tech corporates, privately held companies, independent inventors, academic institutions and investors. The company offers IP licensing management, patent transactions and IP advisory services.

For more information, please visit www.munich-innovation.com

Munich Innovation Group GmbH
von-der-Tann-Strasse 12
80539 München
Germany

This release was published on openPR.